Pasithea Therapeutics Corp. (KTTA) Insider Trading

Name: Pasithea Therapeutics Corp. (KTTA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 22, 2026): Coastlands Capital LP (10% Owner): Purchase of 100,000 shares, $53.0K.

Get alerted when insiders trade KTTA

Email address

Loading company data...

Beta

Loading company details...

Beta